This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (20)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: About 7% of breast cancers are associated with a mutation of BRCA1 or BRCA2.¹ Preventive management in the population of women with genetically determined breast cancer is challenging because there are limited data about strategies, efficacy, and risk-benefit ratios. Women who test positive for a BRCA1 or BRCA2 mutation face difficult decisions about whether to undergo prophylactic mastectomy. A substantial benefit of prophylactic mastectomy was recently documented in women with a family history of breast cancer.² However, from a public health point of view, the impact of any treatment depends not only on efficacy but also on availability, affordability, and acceptability of the procedure. On the assumption that availability and affordability could be achieved, we investigated the acceptability of the procedure.

Methods

Two surveys were conducted in France, one of patients and the other of physicians. The opinions of patients were ascertained with a preconsultation, self-administered questionnaire . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Evaluation of a surveillance programme for women with a family history of breast cancer
Reis et al.
J. Med. Genet. 2009;46:319-323.
ABSTRACT | FULL TEXT  

The impact of a false-positive MRI on the choice for mastectomy in BRCA mutation carriers is limited
Hoogerbrugge et al.
Ann Oncol 2008;19:655-659.
ABSTRACT | FULL TEXT  

Prophylactic mastectomy: ethical issues
Eisinger
Br Med Bull 2007;0:ldm003v1-13.
ABSTRACT | FULL TEXT  

Risk-Reduction Mastectomy: Clinical Issues and Research Needs
Stefanek et al.
JNCI J Natl Cancer Inst 2001;93:1297-1297.
ABSTRACT | FULL TEXT  

Re: Biologic Characteristics of Interval and Screen-Detected Breast Cancers
Eisinger et al.
JNCI J Natl Cancer Inst 2000;92:1533-1534.
FULL TEXT  

Sexual dysfunction in old age
Phanjoo
Adv. Psychiatr. Treat. 2000;6:270-277.
FULL TEXT